About: Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.00 (-0.89%)
TLSA NASDAQ Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd share price
Atividade de preço de TLSA
Último preço
$ 1,000
Variação (24h)
-0,01 USD (0,89%)
Volume
408.72K
Volume (média 4 sem.)
-
Abertura
$ 1,03
Variação do dia
$ 0,97 - $ 1,03
Fechamento anterior
$ 1,01
Último negócio
21 Oct, 7:59 pm GMT+0
Atrasado
21 Oct, 7:59 pm GMT+0
TLSA price performance
Atrasado
21 Oct, 7:59 pm GMT+0
quote.marketSignals